Nanotechnology Applications in Drug Delivery, Diagnostic Contrast Agents, and Implantable Devices

Abstract

This invention leverages nanotechnology to develop advanced solutions for drug delivery, diagnostic imaging, and implantable medical devices. It includes the synthesis and functionalization of nanoparticles for targeted drug delivery, enabling precision medicine with reduced systemic toxicity. Functionalized nanoparticles serve as contrast agents, improving sensitivity and specificity in imaging modalities like MRI, CT, and PET for early disease detection. The invention also integrates nanotechnology-enabled coatings for implantable devices, enhancing biocompatibility, reducing infections, and extending device functionality. Multifunctional nanomaterials that combine therapeutic, diagnostic, and monitoring capabilities offer a transformative approach to theranostic medicine and personalized healthcare.

Specification

Description:The present invention pertains to the field of nanotechnology, focusing on its applications in drug delivery systems, diagnostic contrast agents, and implantable medical devices. It involves the design, synthesis, and functionalization of nanomaterials to enhance the precision, efficiency, and efficacy of biomedical applications. By leveraging the unique properties of nanotechnology, the invention seeks to address critical challenges in medicine, such as targeted drug delivery, early diagnosis, and long-term functionality of implantable devices, thereby improving patient outcomes and reducing treatment side effects. This invention lies in the domain of nanotechnology, specifically its applications in drug delivery systems, diagnostic imaging agents, and implantable medical devices. The invention focuses on designing, synthesizing, and functionalizing nanomaterials for targeted therapeutic delivery, enhanced imaging accuracy, and improved biocompatibility of implants. It aims to integrate nanotechnology into h , Claims:1. A nanotechnology-based system for targeted drug delivery comprising functionalized nanoparticles that encapsulate therapeutic agents and release them at specific pathological sites.
2. The system of claim 1, wherein the nanoparticles are modified with targeting ligands to ensure precision delivery to cancer cells or inflamed tissues.
3. A nanoparticle-based diagnostic contrast agent that enhances imaging sensitivity and resolution for MRI, CT, or PET modalities, as claimed in claim 1.
4. The contrast agent of claim 3, wherein the nanoparticles are functionalized with imaging agents such as gold nanoparticles or quantum dots for optical imaging applications.
5. A nanotechnology-enabled coating for implantable medical devices to improve biocompatibility, as claimed in claim 1, wherein the coating reduces inflammation and bacterial colonization.
6. The coating of claim 5, wherein nanoscale modifications promote tissue integration and extend the functional lifespan of the implant.
7. A multifunctional nanopart

Documents